# Early Access Program for ALXN1840 in Patients With Wilson Disease

> **NCT05686564** · — · NO_LONGER_AVAILABLE · sponsor: **Alexion Pharmaceuticals, Inc.**

## Conditions studied

- Wilson Disease

## Interventions

- **DRUG:** ALXN1840

## Key facts

- **NCT ID:** NCT05686564
- **Lead sponsor:** Alexion Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2023-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05686564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05686564, "Early Access Program for ALXN1840 in Patients With Wilson Disease". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05686564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*